Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Bio-Techne Corp | 9.9B | 42.4x | +23.61% |
33.9B | --- | +3.67% | |
BioNTech SE | 23.9B | 8.1x | --- |
Charles River Laboratories International Inc | 10.1B | 21.8x | +17.91% |
Exelixis Inc | 6.8B | 78.2x | +2.59% |
Genmab A/S | 21.0B | 33.6x | --- |
Halozyme Therapeutics Inc | 5.1B | 21.2x | +25.99% |
ICON PLC | 22.0B | 43.4x | +3.02% |
Incyte Corp | 12.2B | 28.7x | --- |
IQVIA Holdings Inc | 39.1B | 36.4x | +32.58% |
Maravai LifeSciences Holdings Inc | 1.3B | 11.4x | --- |
Regeneron Pharmaceuticals Inc | 89.8B | 23.2x | +23.79% |
Vertex Pharmaceuticals Inc | 91.4B | 26.4x | +65.28% |
Abcam PLC | 3.5B | 1,958.3x | --- |
Agile Therapeutics Inc | 5.3M | 0.2x | --- |
Alkermes Plc | 4.0B | 19.7x | --- |
Amylyx Pharmaceuticals Inc | 956.1M | -915.1x | --- |
Arcturus Therapeutics Holdings Inc | 639.8M | 7.5x | --- |
ARS Pharmaceuticals Inc | 463.7M | 771.0x | --- |
Biomarin Pharmaceutical Inc | 17.2B | 120.3x | --- |
Cannabis Bioscience International Holdings Inc | 8.8M | 0.0x | --- |
Carmell Corp | 57.9M | 25.4x | --- |
Catalyst Pharmaceuticals Inc | 1.5B | 28.2x | --- |
Dynavax Technologies Corp | 1.8B | 37.4x | --- |
Enliven Therapeutics Inc | 464.0M | 3.7x | +33.43% |
Exicure Inc | 4.0M | 0.4x | --- |
Halberd Corp | 3.0M | 2.2x | --- |
International Stem Cell Corp | 896.5K | 4.6x | --- |
Janone Inc | 2.1M | 4.3x | -11.18% |
Kamada Ltd | 271.9M | 38.2x | --- |
LadRx Corp | 792.2K | 23.9x | --- |
MacroGenics Inc | 509.3M | 10.5x | --- |
Malachite Innovations Inc | 10.9M | 3.6x | --- |
Medicure Inc | 11.5M | 15.5x | -27.07% |
Medpace Holdings Inc | 8.3B | 32.3x | +51.60% |
MEI Pharma Inc | 40.9M | 1.0x | --- |
MorphoSys AG | 914.6M | 9.6x | --- |
Neurocrine Biosciences Inc | 11.5B | 62.6x | --- |
Organogenesis Holdings Inc | 336.7M | 27.9x | --- |
POINT Biopharma Global Inc | 1.4B | 16.6x | --- |
Protalix Biotherapeutics Inc | 110.2M | 18.4x | --- |
Puma Biotechnology Inc | 185.5M | 50.9x | --- |
Qiagen NV | 9.4B | 28.7x | --- |
Regen BioPharma Inc | 4.6M | 3.9x | --- |
Revelation Biosciences Inc | 4.6M | -2.0x | --- |
Spero Therapeutics Inc | 60.4M | 143.0x | --- |
Stemtech Corp | 3.2M | 0.1x | --- |
Syros Pharmaceuticals Inc | 57.9M | 1.7x | --- |
TriSalus Life Sciences Inc | 105.3M | 125.1x | --- |
Companies that have maintained their dividend in the face of falling share price lead to high dividend yields. Attention should be paid to the sustainability of these future payments. Generally companies with high dividend yields are mature, stable companies.
Company | Dividend Yield |
---|---|
BIO-TECHNE Corp | 0.51% |
Avid Bioservices Inc | --- |
XOMA Corp | --- |
Alkermes Plc | --- |
Ionis Pharmaceuticals Inc | --- |